Minnesota legislation · 94th Legislature 2025-2026
Minnesota HF3832: Definition of compounding of a drug amended to exempt the use of a flavoring agent.
Status: In committee, April 28, 2026
What the bill says
A bill for an act relating to health; amending the definition of compounding of a drug to exempt the use of a flavoring agent; amending Minnesota Statutes 2024, section 151.01, subdivision 35, by adding a subdivision.
From the introduced text, February 27, 2026:
A bill for an act relating to health; amending the definition of compounding of a drug to exempt the use of a flavoring agent; amending Minnesota Statutes 2024, section 151.01, subdivision 35, by adding a subdivision. Section 1. Minnesota Statutes 2024, section 151.01, subdivision 35, is amended to read: Subd. 35. Compounding. "Compounding" means preparing, mixing, assembling, packaging, and labeling a drug for an identified individual patient as a result of a practitioner's prescription drug order. Compounding also includes anticipatory compounding, as defined in this section, and the preparation of drugs in which all bulk drug substances and components are nonprescription substances. Compounding does not include mixing or reconstituting a drug according to the product's labeling or to the manufacturer's directions, provided that such labeling has been approved by the United States Food and Drug Administration (FDA) or the manufacturer is licensed under section 151.252. Compounding does not include the preparation of a drug for the purpose of, or incident to, research, teaching, or chemical analysis, provided that the drug is not prepared for dispensing or administration to patients. All compounding, regardless of the type of product, must be done pursuant to a prescription drug order unless otherwise permitted in this chapter or by the rules of the board. Compounding does not include a minor deviation from such directions with …
Sponsors
- Natalie Zeleznikar (R) · primary sponsor
- Ned Carroll (D)
Latest actions
- : Referred to Health and Human Services
- : Introduction and first reading
- : Received from House
- : Bill was passed vote: 134-0
- : Third reading
- : House rule 1.21, placed on Calendar for the Day 04/27/2026
- : Second reading
- : Committee report, to adopt
- : Introduction and first reading, referred to Health Finance and Policy
Votes
- CALENDAR FOR THE DAY - Passage (April 27, 2026): 134 yea, 0 nay, passed
Common questions
- What is HF3832?
- HF3832 is a bill in the Minnesota Legislature (94th Legislature 2025-2026): Definition of compounding of a drug amended to exempt the use of a flavoring agent.
- What does HF3832 do?
- In its own words: A bill for an act relating to health; amending the definition of compounding of a drug to exempt the use of a flavoring agent; amending Minnesota Statutes 2024, section 151.01, subdivision 35, by adding a subdivision.
- What is the status of HF3832?
- In committee as of April 28, 2026. Latest action: Referred to Health and Human Services (April 28, 2026).
- Who sponsored HF3832?
- Natalie Zeleznikar (R), with 1 co-sponsor.
- Where is the official record for HF3832?
- On the Minnesota Legislature website: https://www.revisor.mn.gov/bills/bill.php?f=HF3832&y=2025&ssn=0&b=house
Source: official Minnesota record. Tracked by Delilah, AI for legislation across all 50 states and Congress.